Stockscreener 앱 받기
4.02
14.53%
0.51
시장 영업 전:
4.04
0.02
+0.50%
전일 마감가:
$3.51
열려 있는:
$3.53
하루 거래량:
9.63M
Relative Volume:
1.96
시가총액:
$1.07B
수익:
-
순이익/손실:
$-252.18M
주가수익비율:
-3.7925
EPS:
-1.06
순현금흐름:
$-185.29M
1주 성능:
+18.24%
1개월 성능:
-28.09%
6개월 성능:
+102.01%
1년 성능:
+64.08%
1일 변동 폭
$3.45
$4.242
1주일 범위
$3.16
$4.242
52주 변동 폭
$1.26
$7.30
사나 바이오테크놀로지 Stock (SANA) Company Profile
명칭
Sana Biotechnology Inc
전화
(206) 701-7914
주소
188 EAST BLAINE STREET, SUITE 400, SEATTLE
SANA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SANA
Sana Biotechnology Inc
|
4.02 | 934.95M | 0 | -252.18M | -185.29M | -1.06 |
|
VRTX
Vertex Pharmaceuticals Inc
|
432.17 | 109.05B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
784.61 | 82.75B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
445.12 | 56.78B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
917.63 | 56.52B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.51 | 44.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
사나 바이오테크놀로지 Stock (SANA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-24 | 개시 | Wedbush | Outperform |
| 2025-07-03 | 재개 | Morgan Stanley | Overweight |
| 2025-03-18 | 업그레이드 | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-03-14 | 개시 | Jefferies | Buy |
| 2025-01-08 | 업그레이드 | TD Cowen | Hold → Buy |
| 2024-11-05 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-06-26 | 개시 | Rodman & Renshaw | Buy |
| 2024-01-16 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2023-09-25 | 개시 | JMP Securities | Mkt Outperform |
| 2023-09-05 | 개시 | Citigroup | Buy |
| 2023-08-14 | 개시 | TD Cowen | Market Perform |
| 2023-05-02 | 개시 | H.C. Wainwright | Neutral |
| 2021-03-01 | 개시 | BofA Securities | Buy |
| 2021-03-01 | 개시 | Goldman | Neutral |
| 2021-03-01 | 개시 | JP Morgan | Neutral |
| 2021-03-01 | 개시 | Morgan Stanley | Overweight |
모두보기
사나 바이오테크놀로지 주식(SANA)의 최신 뉴스
Sana Biotechnology to Present at December 2025 Investor Conferences - GlobeNewswire
Sana Biotechnology, Inc. to Webcast Presentations at December Investor Conferences - Quiver Quantitative
Sana Biotechnology (NASDAQ: SANA) to Present at 2025 Citi and Evercore Conferences - Stock Titan
Citi Maintained a Buy Rating on Sana Biotechnology (SANA) - MSN
Why Sana Biotechnology Inc. stock could benefit from AI revolutionWatch List & Fast Gaining Stock Strategy Reports - newser.com
Can Sana Biotechnology Inc. stock deliver surprise earnings beat2025 Year in Review & Fast Gain Stock Trading Tips - newser.com
How Sana Biotechnology Inc. stock benefits from global expansion2025 Biggest Moves & Free Reliable Trade Execution Plans - newser.com
Evaluating Sana Biotechnology Inc. with trendline analysisJuly 2025 Sentiment & Expert Curated Trade Ideas - newser.com
What valuation multiples suggest for Sana Biotechnology Inc. stock2025 Big Picture & Free AI Powered Buy and Sell Recommendations - newser.com
Using Ichimoku Cloud for Sana Biotechnology Inc. technicalsJuly 2025 Momentum & Fast Gain Swing Alerts - newser.com
Will Sana Biotechnology Inc. stock benefit from automationBull Run & Daily Risk Controlled Trade Plans - newser.com
The Biotech Sector is Seeing a Major Boost From Programmable Cell Therapies in Chronic Disease Care - Markets Financial Content
Sana Biotechnology (SANA) Wins Analyst Support With Strategic Focus and Cash Strength - Insider Monkey
Can Sana Biotechnology Inc. recover in the next quarterTreasury Yields & Fast Exit and Entry Trade Guides - newser.com
Can Sana Biotechnology’s (SANA) Leaner Cost Structure Strengthen Its Long-Term Competitive Position? - Yahoo Finance
Sana Biotechnology Beats Expectations in Q3 Report - StocksToTrade
Identifying reversal signals in Sana Biotechnology Inc.Fed Meeting & Accurate Entry/Exit Alerts - newser.com
Why Sana Biotechnology Inc. stock is a must watch in 20252025 Geopolitical Influence & Risk Controlled Daily Trade Plans - newser.com
Sana Biotechnology Beats Earnings Expectations, Gains Investor Confidence - timothysykes.com
Is Sana Biotechnology Inc. stock a smart buy before Fed meetingWeekly Gains Report & Fast Exit and Entry Trade Guides - newser.com
Earnings visualization tools for Sana Biotechnology Inc.2025 Support & Resistance & High Conviction Buy Zone Picks - newser.com
Sana Biotechnology’s Q3 Reports Beat Expectations, Stock Target Raised to $8 - StocksToTrade
Is Sana Biotechnology's (SANA) Ongoing Loss Reduction Shaping Its Long-Term Investment Narrative? - simplywall.st
Custom strategy builders for tracking Sana Biotechnology Inc.Gap Up & Safe Capital Allocation Plans - newser.com
Visual trend scoring systems applied to Sana Biotechnology Inc.2025 Institutional Moves & Growth Focused Entry Point Reports - newser.com
What MACD signals say about Sana Biotechnology Inc.July 2025 Institutional & Accurate Technical Buy Alerts - newser.com
Long term hold vs stop loss in Sana Biotechnology Inc.Earnings Growth Summary & Stock Portfolio Risk Control - newser.com
Using economic indicators to assess Sana Biotechnology Inc. potentialJuly 2025 Snapshot & AI Forecasted Entry/Exit Points - newser.com
사나 바이오테크놀로지 (SANA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.76%
2.16%
자본화:
|
볼륨(24시간):